Industry: Chemical & Material
Published Date: 2025-10-03
Pages: 167 Pages
Report ld: 5114925
Request Sample
Customized Report
The global 4-Hydroxythiobenzamide market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
4-Hydroxythiobenzamide is used in the synthesis of PPARa agonists used in increasing HDLc levels. Also used in the synthesis of potent CDK5 inhibitors in the treatment of AlzheimerтАЩs disease.
From a downstream perspective, Medical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
4-Hydroxythiobenzamide leading manufacturers including DSL Chemicals, BOC Sciences, BioCrick, Endeavour Speciality Chemicals, ECHEMI, Oakwood Chemical, Shandong Boaote Biotechnology Co., Ltd., Qufu Hongli Chemical Co., Ltd., Qingzhou Aoxing Chemical Co., Ltd., Shanghai Youpeng Chemical Co., Ltd., etc., dominate supply; the top five capture approximately % of global revenue, with DSL Chemicals leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global 4-Hydroxythiobenzamide market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the 4-Hydroxythiobenzamide study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to 4-Hydroxythiobenzamide: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global 4-Hydroxythiobenzamide Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Above 99%
1.2.3 Above 98%
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global 4-Hydroxythiobenzamide Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Chemical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global 4-Hydroxythiobenzamide Revenue Estimates and Forecasts 2020-2031
2.2 Global 4-Hydroxythiobenzamide Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global 4-Hydroxythiobenzamide Sales Estimates and Forecasts 2020-2031
2.4 Global 4-Hydroxythiobenzamide Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global 4-Hydroxythiobenzamide Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global 4-Hydroxythiobenzamide Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global 4-Hydroxythiobenzamide Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Above 99% Market Size by Manufacturers
4.5.2 Above 98% Market Size by Manufacturers
4.5.3 Others Market Size by Manufacturers
4.6 Global 4-Hydroxythiobenzamide Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global 4-Hydroxythiobenzamide Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global 4-Hydroxythiobenzamide Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global 4-Hydroxythiobenzamide Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global 4-Hydroxythiobenzamide Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America 4-Hydroxythiobenzamide Sales and Revenue by Type (2020-2031)
7.4 North America 4-Hydroxythiobenzamide Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America 4-Hydroxythiobenzamide Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe 4-Hydroxythiobenzamide Sales and Revenue by Type (2020-2031)
8.4 Europe 4-Hydroxythiobenzamide Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe 4-Hydroxythiobenzamide Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific 4-Hydroxythiobenzamide Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific 4-Hydroxythiobenzamide Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific 4-Hydroxythiobenzamide Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America 4-Hydroxythiobenzamide Sales and Revenue by Type (2020-2031)
10.4 Central and South America 4-Hydroxythiobenzamide Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America 4-Hydroxythiobenzamide Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa 4-Hydroxythiobenzamide Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa 4-Hydroxythiobenzamide Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa 4-Hydroxythiobenzamide Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 DSL Chemicals
12.1.1 DSL Chemicals Corporation Information
12.1.2 DSL Chemicals Business Overview
12.1.3 DSL Chemicals 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.1.4 DSL Chemicals 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 DSL Chemicals 4-Hydroxythiobenzamide Sales by Product in 2024
12.1.6 DSL Chemicals 4-Hydroxythiobenzamide Sales by Application in 2024
12.1.7 DSL Chemicals 4-Hydroxythiobenzamide Sales by Geographic Area in 2024
12.1.8 DSL Chemicals 4-Hydroxythiobenzamide SWOT Analysis
12.1.9 DSL Chemicals Recent Developments
12.2 BOC Sciences
12.2.1 BOC Sciences Corporation Information
12.2.2 BOC Sciences Business Overview
12.2.3 BOC Sciences 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.2.4 BOC Sciences 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 BOC Sciences 4-Hydroxythiobenzamide Sales by Product in 2024
12.2.6 BOC Sciences 4-Hydroxythiobenzamide Sales by Application in 2024
12.2.7 BOC Sciences 4-Hydroxythiobenzamide Sales by Geographic Area in 2024
12.2.8 BOC Sciences 4-Hydroxythiobenzamide SWOT Analysis
12.2.9 BOC Sciences Recent Developments
12.3 BioCrick
12.3.1 BioCrick Corporation Information
12.3.2 BioCrick Business Overview
12.3.3 BioCrick 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.3.4 BioCrick 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 BioCrick 4-Hydroxythiobenzamide Sales by Product in 2024
12.3.6 BioCrick 4-Hydroxythiobenzamide Sales by Application in 2024
12.3.7 BioCrick 4-Hydroxythiobenzamide Sales by Geographic Area in 2024
12.3.8 BioCrick 4-Hydroxythiobenzamide SWOT Analysis
12.3.9 BioCrick Recent Developments
12.4 Endeavour Speciality Chemicals
12.4.1 Endeavour Speciality Chemicals Corporation Information
12.4.2 Endeavour Speciality Chemicals Business Overview
12.4.3 Endeavour Speciality Chemicals 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.4.4 Endeavour Speciality Chemicals 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Endeavour Speciality Chemicals 4-Hydroxythiobenzamide Sales by Product in 2024
12.4.6 Endeavour Speciality Chemicals 4-Hydroxythiobenzamide Sales by Application in 2024
12.4.7 Endeavour Speciality Chemicals 4-Hydroxythiobenzamide Sales by Geographic Area in 2024
12.4.8 Endeavour Speciality Chemicals 4-Hydroxythiobenzamide SWOT Analysis
12.4.9 Endeavour Speciality Chemicals Recent Developments
12.5 ECHEMI
12.5.1 ECHEMI Corporation Information
12.5.2 ECHEMI Business Overview
12.5.3 ECHEMI 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.5.4 ECHEMI 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 ECHEMI 4-Hydroxythiobenzamide Sales by Product in 2024
12.5.6 ECHEMI 4-Hydroxythiobenzamide Sales by Application in 2024
12.5.7 ECHEMI 4-Hydroxythiobenzamide Sales by Geographic Area in 2024
12.5.8 ECHEMI 4-Hydroxythiobenzamide SWOT Analysis
12.5.9 ECHEMI Recent Developments
12.6 Oakwood Chemical
12.6.1 Oakwood Chemical Corporation Information
12.6.2 Oakwood Chemical Business Overview
12.6.3 Oakwood Chemical 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.6.4 Oakwood Chemical 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Oakwood Chemical Recent Developments
12.7 Shandong Boaote Biotechnology Co., Ltd.
12.7.1 Shandong Boaote Biotechnology Co., Ltd. Corporation Information
12.7.2 Shandong Boaote Biotechnology Co., Ltd. Business Overview
12.7.3 Shandong Boaote Biotechnology Co., Ltd. 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.7.4 Shandong Boaote Biotechnology Co., Ltd. 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Shandong Boaote Biotechnology Co., Ltd. Recent Developments
12.8 Qufu Hongli Chemical Co., Ltd.
12.8.1 Qufu Hongli Chemical Co., Ltd. Corporation Information
12.8.2 Qufu Hongli Chemical Co., Ltd. Business Overview
12.8.3 Qufu Hongli Chemical Co., Ltd. 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.8.4 Qufu Hongli Chemical Co., Ltd. 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Qufu Hongli Chemical Co., Ltd. Recent Developments
12.9 Qingzhou Aoxing Chemical Co., Ltd.
12.9.1 Qingzhou Aoxing Chemical Co., Ltd. Corporation Information
12.9.2 Qingzhou Aoxing Chemical Co., Ltd. Business Overview
12.9.3 Qingzhou Aoxing Chemical Co., Ltd. 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.9.4 Qingzhou Aoxing Chemical Co., Ltd. 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Qingzhou Aoxing Chemical Co., Ltd. Recent Developments
12.10 Shanghai Youpeng Chemical Co., Ltd.
12.10.1 Shanghai Youpeng Chemical Co., Ltd. Corporation Information
12.10.2 Shanghai Youpeng Chemical Co., Ltd. Business Overview
12.10.3 Shanghai Youpeng Chemical Co., Ltd. 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.10.4 Shanghai Youpeng Chemical Co., Ltd. 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Shanghai Youpeng Chemical Co., Ltd. Recent Developments
12.11 Shanghai Kangtuo Chemical Co., Ltd.
12.11.1 Shanghai Kangtuo Chemical Co., Ltd. Corporation Information
12.11.2 Shanghai Kangtuo Chemical Co., Ltd. Business Overview
12.11.3 Shanghai Kangtuo Chemical Co., Ltd. 4-Hydroxythiobenzamide Product Models, Descriptions and Specifications
12.11.4 Shanghai Kangtuo Chemical Co., Ltd. 4-Hydroxythiobenzamide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Shanghai Kangtuo Chemical Co., Ltd. Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 4-Hydroxythiobenzamide Industry Chain
13.2 4-Hydroxythiobenzamide Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 4-Hydroxythiobenzamide Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 4-Hydroxythiobenzamide Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 4-Hydroxythiobenzamide Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global 4-Hydroxythiobenzamide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global 4-Hydroxythiobenzamide market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-04-28
Pages: 135
USD 4250.00
(Single User License)
The global 4-Hydroxythiobenzamide market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-04-28
Pages: 133
USD 4900.00
(Single User License)
The global market for 4-Hydroxythiobenzamide was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 132
USD 3950.00
(Single User License)
The global 4-Hydroxythiobenzamide market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 126
USD 2900.00
(Single User License)
The global 4-Hydroxythiobenzamide market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 91
USD 4250.00
(Single User License)
The global market for 4-Hydroxythiobenzamide was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 112
USD 3950.00
(Single User License)
The global market for 4-Hydroxythiobenzamide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-14
Pages: 101
USD 2900.00
(Single User License)
4-Hydroxythiobenzamide is used in the synthesis of PPARa agonists used in increasing HDLc levels. Also used in the synthesis of potent CDK5 inhibitors in the treatment of AlzheimerтАЩs disease.
Published Date: 2024-04-14
Pages: 107
USD 4900.00
(Single User License)
The global 4-Hydroxythiobenzamide market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-04-28
Pages: 135
The global 4-Hydroxythiobenzamide market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-04-28
Pages: 133
The global market for 4-Hydroxythiobenzamide was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 132
The global 4-Hydroxythiobenzamide market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 126
The global 4-Hydroxythiobenzamide market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 91
The global market for 4-Hydroxythiobenzamide was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 112
The global market for 4-Hydroxythiobenzamide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 101
4-Hydroxythiobenzamide is used in the synthesis of PPARa agonists used in increasing HDLc levels. Also used in the synthesis of potent CDK5 inhibitors in the treatment of AlzheimerтАЩs disease.
Published: 2024-04-14
Pages: 107
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now